about
Epimutation and cancer: a new carcinogenic mechanism of Lynch syndrome (Review)Highlight: BRCA1 and BRCA2 proteins in breast cancerMutational processes molding the genomes of 21 breast cancersOn the epistemological crisis in genomicsCommon genetic variation in candidate genes and susceptibility to subtypes of breast cancerEZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cellsStatistical significance for genomewide studiesOvarian surface epithelium: family history and early events in ovarian cancerMicroarrays and molecular markers for tumor classificationExpression profiling of human renal carcinomas with functional taxonomic analysis.BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data.Multi-class cancer classification by total principal component regression (TPCR) using microarray gene expression dataCombining gene expression data from different generations of oligonucleotide arraysIterative class discovery and feature selection using Minimal Spanning TreesMulticlass discovery in array dataDetermination of the differentially expressed genes in microarray experiments using local FDRBRCA1-mediated repression of select X chromosome genesHistopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.Molecular tumor profiling: translating genomic insights into clinical advancesMicroarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumorsMany accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery.Genetic alteration and gene expression modulation during cancer progressionOptimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis.Utilization of a labeled tracking oligonucleotide for visualization and quality control of spotted 70-mer arraysTests for finding complex patterns of differential expression in cancers: towards individualized medicineThe diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesionsSemi-supervised methods to predict patient survival from gene expression dataCharacterization of adjacent breast tumors using oligonucleotide microarraysThe promise of microarrays in the management and treatment of breast cancerMulticlass cancer classification by using fuzzy support vector machine and binary decision tree with gene selection.Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.Searching for differentially expressed gene combinations.Dissecting systems-wide data using mixture models: application to identify affected cellular processes.Sample phenotype clusters in high-density oligonucleotide microarray data sets are revealed using Isomap, a nonlinear algorithm.A comparative study of discriminating human heart failure etiology using gene expression profilesMicroarray missing data imputation based on a set theoretic framework and biological knowledgeGene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.ITTACA: a new database for integrated tumor transcriptome array and clinical data analysis.Comparative study of classification algorithms for immunosignaturing dataGene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
P2860
Q22255392-A223F934-FBB6-406A-90CC-A97D32078662Q24307401-BE567147-DC88-4766-A0E4-E643AA208E20Q24620915-049426FB-3F59-4A78-B766-C45600201A72Q24652735-18DF1C8D-13E8-4333-8A38-F354F9190652Q24658131-1289BC58-C516-461F-B86E-D74374596E0FQ24672969-9F79AF5F-5C91-494B-9CB8-EA930D5B3EFFQ24681264-A5DDD737-671F-418B-9548-773174A8CA64Q24791495-63EA69C5-35B9-4ABD-A6D5-5EA16B50BF86Q24791738-8A7DEC30-771D-440E-9188-4EB3B46F8066Q24791890-25C27581-2F3E-461B-BCED-A9030330CE0DQ24792694-8D4164AD-FB60-4BC6-89CF-887A789E42BDQ24793372-3386835F-2231-4063-A925-C8592377F21DQ24794137-C1B6F471-D3A0-4108-ABB9-CAA8CB2B2C9BQ24795482-7015F54F-C9FC-4478-96C1-5950DEC5E082Q24795508-0ED4507F-06A3-4D4C-BB0E-32724468A8E4Q24795812-5E760F79-1CDE-471C-BB00-89EC4402647BQ24796376-F94407C5-5613-465B-8532-0BF994CE826CQ24796660-2B27D5B9-09E3-4E8E-AE55-A7F6D1BBFB79Q24797250-82F4D5E0-9128-4358-A1BD-F8F6D217D4DBQ24797625-24B3F458-F85B-4C28-854D-D683FA2049B3Q24798742-637C53CB-BD26-4967-94E2-00232387B318Q24798750-EFFEF988-D835-46EF-89D1-033FC5207323Q24798929-30B7E662-FEE8-45E3-9D17-7742B6C9C630Q24799575-52B903E1-F7E7-4CC6-A4EA-5C8FC7727042Q24801330-B2AC3221-38B5-4294-8541-27C1A0AA7F08Q24803014-B5FEDDC6-AD94-4C16-9F60-A5E63E84C2D4Q24804682-E8C1F434-0D9F-41EF-961D-4FA7A28BC25EQ24805954-7EBC8743-1F1F-4DA3-AB51-DC16C2E6BAF1Q24810272-73CD0C1E-D405-4C28-A75B-16285EDD42B4Q24811720-4596CC94-6443-4A2C-BB69-14ABAA403463Q24812718-6ADA64C1-5787-4800-A7CB-F127D1484420Q24812766-7DB26FC9-E027-40F5-9152-1D46940456F1Q24815072-49468233-6416-43FD-A3D3-91C63FE4E469Q24815085-3CCF401A-AE58-4F6D-A2C7-8A65ACED34E7Q24815374-3D3BDA23-689D-40A2-9AC2-8EBB3957AD5EQ25256642-DF3C7A49-F21E-4FAF-8779-20690FDA8D1CQ25257621-2B1E74A2-014D-4A8A-AF35-08ADDE6A40A7Q25257652-91068E9F-CC1E-4AE1-8EE2-D9C698C3BADCQ27496490-A34A682D-C231-494A-921D-FC86806AE24CQ27860709-B83D0F6C-F144-4971-A6FF-EEA29A660154
P2860
description
article
@en
im Februar 2001 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2001
@uk
name
Gene-Expression Profiles in Hereditary Breast Cancer
@en
Gene-Expression Profiles in Hereditary Breast Cancer
@nl
type
label
Gene-Expression Profiles in Hereditary Breast Cancer
@en
Gene-Expression Profiles in Hereditary Breast Cancer
@nl
prefLabel
Gene-Expression Profiles in Hereditary Breast Cancer
@en
Gene-Expression Profiles in Hereditary Breast Cancer
@nl
P2093
P50
P1476
Gene-expression profiles in hereditary breast cancer
@en
P2093
Bubendorf L
Dougherty E
Gusterson B
Johannsson O
P304
P356
10.1056/NEJM200102223440801
P407
P577
2001-02-01T00:00:00Z